Barclays’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $538M | Sell |
1,529,613
-390,882
| -20% | -$139M | 0.13% | 119 |
|
|
2025
Q4 | $629M | Sell |
1,920,495
-774,855
| -29% | -$246M | 0.15% | 96 |
|
|
2025
Q3 | $761M | Buy |
2,695,350
+302,630
| +13% | +$87.8M | 0.16% | 80 |
|
|
2025
Q2 | $668M | Sell |
2,392,720
-166,875
| -7% | -$47.3M | 0.15% | 84 |
|
|
2025
Q1 | $797M | Buy |
2,559,595
+576,630
| +29% | +$170M | 0.23% | 62 |
|
|
2024
Q4 | $517M | Sell |
1,982,965
-338,883
| -15% | -$101M | 0.14% | 85 |
|
|
2024
Q3 | $748M | Buy |
2,321,848
+438,293
| +23% | +$143M | 0.2% | 64 |
|
|
2024
Q2 | $589M | Sell |
1,883,555
-2,459,106
| -57% | -$722M | 0.18% | 78 |
|
|
2024
Q1 | $1.23B | Buy |
4,342,661
+1,426,434
| +49% | +$417M | 0.43% | 30 |
|
|
2023
Q4 | $840M | Buy |
2,916,227
+1,385,762
| +91% | +$378M | 0.31% | 47 |
|
|
2023
Q3 | $411M | Sell |
1,530,465
-159,722
| -9% | -$39.9M | 0.26% | 73 |
|
|
2023
Q2 | $375M | Buy |
1,690,187
+890,242
| +111% | +$207M | 0.24% | 82 |
|
|
2023
Q1 | $193M | Sell |
799,945
-921,588
| -54% | -$226M | 0.09% | 145 |
|
|
2022
Q4 | $452M | Buy |
1,721,533
+714,274
| +71% | +$191M | 0.2% | 72 |
|
|
2022
Q3 | $227M | Buy |
1,007,259
+163,726
| +19% | +$39.7M | 0.25% | 87 |
|
|
2022
Q2 | $205M | Sell |
843,533
-420,372
| -33% | -$103M | 0.13% | 119 |
|
|
2022
Q1 | $306M | Sell |
1,263,905
-1,769,873
| -58% | -$407M | 0.24% | 88 |
|
|
2021
Q4 | $683M | Buy |
3,033,778
+984,406
| +48% | +$208M | 0.25% | 69 |
|
|
2021
Q3 | $436M | Buy |
2,049,372
+586,707
| +40% | +$135M | 0.2% | 80 |
|
|
2021
Q2 | $357M | Buy |
1,462,665
+226,790
| +18% | +$55.8M | 0.17% | 90 |
|
|
2021
Q1 | $308M | Buy |
1,235,875
+265,594
| +27% | +$63.4M | 0.17% | 90 |
|
|
2020
Q4 | $223M | Buy |
970,281
+98,667
| +11% | +$22.7M | 0.12% | 130 |
|
|
2020
Q3 | $222M | Buy |
871,614
+121,433
| +16% | +$30.1M | 0.13% | 118 |
|
|
2020
Q2 | $177M | Sell |
750,181
-119,190
| -14% | -$27.2M | 0.14% | 114 |
|
|
2020
Q1 | $176M | Sell |
869,371
-596,754
| -41% | -$130M | 0.14% | 100 |
|
|
2019
Q4 | $353M | Sell |
1,466,125
-110,649
| -7% | -$24.4M | 0.2% | 83 |
|
|
2019
Q3 | $305M | Sell |
1,576,774
-398,116
| -20% | -$76.4M | 0.19% | 91 |
|
|
2019
Q2 | $364M | Buy |
1,974,890
+645,704
| +49% | +$116M | 0.22% | 71 |
|
|
2019
Q1 | $253M | Buy |
1,329,186
+73,123
| +6% | +$14M | 0.17% | 85 |
|
|
2018
Q4 | $245M | Sell |
1,256,063
-146,047
| -10% | -$28.5M | 0.19% | 79 |
|
|
2018
Q3 | $291M | Sell |
1,402,110
-9,535
| -0.7% | -$1.88M | 0.2% | 75 |
|
|
2018
Q2 | $261M | Sell |
1,411,645
-889,143
| -39% | -$157M | 0.22% | 68 |
|
|
2018
Q1 | $392M | Buy |
2,300,788
+762,949
| +50% | +$140M | 0.3% | 56 |
|
|
2017
Q4 | $267M | Buy |
1,537,839
+335,122
| +28% | +$59.3M | 0.22% | 80 |
|
|
2017
Q3 | $224M | Sell |
1,202,717
-5,451
| -0.5% | -$966K | 0.23% | 56 |
|
|
2017
Q2 | $208M | Sell |
1,208,168
-846,921
| -41% | -$138M | 0.22% | 60 |
|
|
2017
Q1 | $337M | Buy |
2,055,089
+1,493,651
| +266% | +$248M | 0.37% | 33 |
|
|
2016
Q4 | $82.1M | Sell |
561,438
-12,335
| -2% | -$1.86M | 0.09% | 175 |
|
|
2016
Q3 | $95.7M | Sell |
573,773
-111,495
| -16% | -$18.9M | 0.11% | 143 |
|
|
2016
Q2 | $104M | Sell |
685,268
-73,605
| -10% | -$11.4M | 0.14% | 119 |
|
|
2016
Q1 | $113M | Sell |
758,873
-150,755
| -17% | -$22.4M | 0.17% | 96 |
|
|
2015
Q4 | $147M | Buy |
909,628
+230,837
| +34% | +$36.3M | 0.18% | 98 |
|
|
2015
Q3 | $93.7M | Sell |
678,791
-248,056
| -27% | -$39.1M | 0.11% | 151 |
|
|
2015
Q2 | $142M | Buy |
926,847
+179,406
| +24% | +$28.7M | 0.16% | 99 |
|
|
2015
Q1 | $119M | Sell |
747,441
-546,200
| -42% | -$86M | 0.14% | 126 |
|
|
2014
Q4 | $206M | Buy |
1,293,641
+1,975
| +0.2% | +$308K | 0.2% | 76 |
|
|
2014
Q3 | $181M | Buy |
1,291,666
+533,017
| +70% | +$69.6M | 0.17% | 80 |
|
|
2014
Q2 | $89.5M | Buy |
758,649
+12,771
| +2% | +$1.48M | 0.09% | 168 |
|
|
2014
Q1 | $91.7M | Sell |
745,878
-190,924
| -20% | -$23.2M | 0.1% | 168 |
|
|
2013
Q4 | $107M | Buy |
936,802
+120,996
| +15% | +$13.8M | 0.11% | 143 |
|
|
2013
Q3 | $90.6M | Buy |
815,806
+254,153
| +45% | +$27.6M | 0.11% | 138 |
|
|
2013
Q2 | $55.4M | Buy |
+561,653
| New | +$58.3M | 0.07% | 242 |
|
Other funds holding AMGN
VCM
VPM
Barclays's AMGN Position: Q1 2026 in Review
Barclays reduced its Amgen (AMGN) stake by 20% in Q1 2026, selling an estimated $139M and leaving 1,529,613 shares worth $538M. The position accounts for 0.13% of the portfolio, ranked #119.
Barclays first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.23B in Q1 2024. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Barclays held 1,529,613 shares of Amgen worth $538M as of Q1 2026.
- Barclays sold 390,882 Amgen shares in Q1 2026, an estimated $139M.
- Amgen made up 0.13% of Barclays's portfolio in Q1 2026, its #119 holding.
- Barclays first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
- Barclays's Amgen position peaked at $1.23B in Q1 2024.
- 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.